New Rule Would Require Breast Density Disclosure A proposed federal rule says that patients must be informed after mammograms if they have dense breasts. by Carly Weeks FORWARD LOOK Lynch Syndrome Linked to More Cancers Study findings suggest patient screening has been too narrow. by Sharon Tregaskis POLICY MATTERS Eliminating HPV-Related Cancer HPV vaccination and screening can help eradicate cervical cancer and other malignancies. by Anna R. Giuliano, PhD Young Colorectal Cancer Patients Are Often Misdiagnosed A new survey suggests that young adults with colorectal cancer struggle to receive an accurate, prompt diagnosis. by Bradley Jones Forward Look In Women, Lung Cancer Rates Are Rising Worldwide Lung cancer deaths are set to surpass breast cancer deaths in many regions. by Cameron Walker The Health Legacy of 9/11 People who were directly affected by the Sept. 11 terrorist attacks can receive screenings and care for medical conditions, including certain cancers, through the World Trade Center Health Program. by Brad Jones A New Guideline for Cervical Cancer Screening Physicians Lee Learman and Francisco Garcia discuss the updated U.S. Preventive Services Task Force guideline and the need to increase access to cervical cancer screening. by Anna Azvolinsky Some Pancreatic Cancers Are Hereditary A trio of recent studies indicates that pancreatic cancer is, in some cases, linked to mutations passed down from generation to generation. by Cheryl Platzman Weinstock Predicting Acute Myeloid Leukemia Two studies identify genetic mutations that could predict the risk of an aggressive blood cancer up to a decade before it is diagnosed. by Anna Azvolinsky From the Editor-in-Chief DNA Profiling Moves From Forensics to Diagnostics DNA profiling technologies are providing new ways to detect and monitor cancer. by William G. Nelson, MD, PhD next Cancer Talk New Rule Would Require Breast Density Disclosure A proposed federal rule says that patients must be informed after mammograms if they have dense breasts. by Carly Weeks PARP Inhibitors in Pancreatic Cancer Drugs that target DNA repair enzymes may provide alternatives to long-term chemotherapy for some patients with pancreatic cancer. by Kate Yandell Telling Their Stories Through Posters Survivors and advocates display their posters alongside the work of thousands of cancer researchers. by Kevin McLaughlin The Crowded Field of Checkpoint Inhibitors Drug developers behind the six currently approved checkpoint inhibitors discuss the pros and cons of competition in the field. by Kate Yandell More Posts